Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.6 USD | -6.04% | -11.95% | +11.55% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
Business Summary
Number of employees: 628
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 20-09-30 |
Founder | 71 | 14-11-30 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Leonard Sender
COO | Chief Operating Officer | - | 20-02-29 |
John Lee
CTO | Chief Tech/Sci/R&D Officer | 56 | 19-02-28 |
Sandeep K. Reddy
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Hans Klingemann
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Enrique Dilone
CTO | Chief Tech/Sci/R&D Officer | 57 | 23-08-13 |
Barry Simon
BRD | Director/Board Member | 59 | 06-12-31 |
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 14-11-30 | |
Cheryl Cohen
BRD | Director/Board Member | 58 | 19-05-31 |
Wesley Clark
BRD | Director/Board Member | 78 | 21-02-28 |
Director/Board Member | 69 | 21-02-28 | |
Barry Simon
BRD | Director/Board Member | 59 | 06-12-31 |
Michael Blaszyk
BRD | Director/Board Member | 71 | 15-06-30 |
Richard Adcock
CEO | Chief Executive Officer | 55 | 20-09-30 |
John Brennan
BRD | Director/Board Member | 67 | 21-02-28 |
Linda Maxwell
BRD | Director/Board Member | 50 | 21-03-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 691,731,761 | 153,590,928 ( 22.20 %) | 163,800 ( 0.0237 %) | 22.20 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.55% | 3.87B | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+3.38% | 22.58B | |
-14.57% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- IBRX Stock
- Company ImmunityBio, Inc.